Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose–volume histogram analysis and comparison with conventional chemoradiation

This publication has 23 references indexed in Scilit:

• Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104
  Journal of Clinical Oncology, 2002
• Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide
  New England Journal of Medicine, 1999
• Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.
  Journal of Clinical Oncology, 1997
• Potential pitfalls in the use of p-values and in interpretation of significance levels
  Radiotherapy and Oncology, 1994
• Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
  International Journal of Radiation Oncology*Biology*Physics, 1994
• A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Fitting of normal tissue tolerance data to an analytic function
  International Journal of Radiation Oncology*Biology*Physics, 1991